Gentamycin/poly(lactic acid) blends aimed at sustained release local antibiotic therapy administered per-operatively. II. The case of gentamycin sulfate in high molecular weight poly(dl-lactic acid) and poly(l-lactic acid)

Journal of Controlled Release

Volumn 23, Issue 3, 1993, Pages 221-230

  Mauduit, J ^a   Bukh, N ^b   Vert, M ^a  

^a UNIV MONTPELLIER   (France)

^b Bukh Meditec ^*  (Denmark)

Author keywords

Gentamycin sulfate; Per operative therapy; Poly(dl lactic acid); Poly (dl lactic acid)

Indexed keywords

GENTAMICIN; LACTIC ACID; POLYLACTIC ACID;

ARTICLE; CONTROLLED STUDY; DIFFERENTIAL SCANNING CALORIMETRY; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG RELEASE; MOLECULAR WEIGHT; PHARMACEUTICS; PRIORITY JOURNAL; SCANNING ELECTRON MICROSCOPY; X RAY DIFFRACTION;

EID: 0027472079     PISSN: 01683659     EISSN: None     Source Type: Journal    
DOI: 10.1016/0168-3659(93)90003-N     Document Type: Article

References (11)

1. Gentamycin/poly(lactic acid) blends aimed at sustained release local antibiotic therapy administered per-operatively. I. The case of gentamycin base and gentamycin sulfate in poly(dl-lactic acid) oligomers
2. Sustained release of sulfamethizole, 5-fluorouracil and doxorubicin from ethylcellulose/polylactic acid microcapsules
3. Erythromycin poly(lactic acid) microspheres for sustained delivery and reduced tissue irritation
4. Release of antibiotic from composites of Hydroxyapatite and poly(lactic acid)
5. Sustained release of sulphadiazine
6. Bioresorbable plastic materials for bone surgery
7. Bioresorbable polymers for temporary therapeutic applications
8. Mechanism of sustained-action medication:theoretical analysis of rate of release of solid drugs dispersed in solid matrices
9. Microsphères à base de cisplatine et de polymères biorésorbables du type poly(α-hydroxy-acide) pour chimioembolisation
10. Structure-property relationships in the case of degradation of massive aliphatic poly (α-hydroxy acids) in aqueous media, part 1:poly(dl-lactic acid)